omeprazole has been researched along with Giardia duodenalis Infection in 10 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Those who tested positive for giardiasis (Group 1) were assigned to receive Tinidazole 2." | 3.79 | Giardia intestinalis in patients with nonulcer dyspepsia. ( Abulhasan, M; Albadry, A; Eida, M; Elshazly, TA, 2013) |
| " Etiologic investigations led to the discovery of Giardiasis lamblia on duodenal biopsies and a long-term treatment with proton pump inhibitors (PPI) (omeprazole followed by esomeprazole), both being recently described as causal factors of hypomagnesemic hypoparathyroidism." | 3.74 | [Chronic use of proton-pump inhibitors associated with giardiasis: A rare cause of hypomagnesemic hypoparathyroidism?]. ( Caron, J; Durlach, V; François, M; Lévy-Bohbot, N, 2008) |
| "Two patients who developed gastric giardiasis after 2 weeks of treatment with omeprazole 20 mg b." | 3.69 | Proton-pump inhibition and gastric giardiasis: a causal or casual association? ( Bourgain, C; Devis, G; Fernandes, E; Reynaert, H; Smekens, L, 1995) |
| "Giardiasis is a worldwide parasitic disease that affects mainly children and immunosuppressed people." | 1.46 | Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation. ( Calderon-Jaimes, E; Castillo-Villanueva, A; Esturau-Escofet, N; Gómez-Manzo, S; Hernández-Ochoa, B; Marcial-Quino, J; Martínez-Gordillo, M; Méndez, ST; Nava-Zuazo, C; Navarrete-Vázquez, G; Oria-Hernández, J; Palencia-Hernández, G; Ponce-Macotela, M; Reyes-Vivas, H; Rufino-González, Y; Torres-Arroyo, A, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riches, A | 1 |
| Hart, CJS | 1 |
| Trenholme, KR | 1 |
| Skinner-Adams, TS | 1 |
| Fernández-Lainez, C | 1 |
| de la Mora-de la Mora, I | 1 |
| García-Torres, I | 1 |
| Enríquez-Flores, S | 1 |
| Flores-López, LA | 1 |
| Gutiérrez-Castrellón, P | 1 |
| Yépez-Mulia, L | 1 |
| Matadamas-Martínez, F | 1 |
| de Vos, P | 1 |
| López-Velázquez, G | 1 |
| Hernández-Ochoa, B | 1 |
| Navarrete-Vázquez, G | 1 |
| Nava-Zuazo, C | 1 |
| Castillo-Villanueva, A | 1 |
| Méndez, ST | 1 |
| Torres-Arroyo, A | 1 |
| Gómez-Manzo, S | 1 |
| Marcial-Quino, J | 1 |
| Ponce-Macotela, M | 1 |
| Rufino-González, Y | 1 |
| Martínez-Gordillo, M | 1 |
| Palencia-Hernández, G | 1 |
| Esturau-Escofet, N | 1 |
| Calderon-Jaimes, E | 1 |
| Oria-Hernández, J | 1 |
| Reyes-Vivas, H | 1 |
| Abulhasan, M | 1 |
| Elshazly, TA | 1 |
| Eida, M | 1 |
| Albadry, A | 1 |
| François, M | 1 |
| Lévy-Bohbot, N | 1 |
| Caron, J | 1 |
| Durlach, V | 1 |
| Kreft, B | 1 |
| Oehme, A | 1 |
| Lübbert, C | 1 |
| Marsch, WC | 1 |
| Kekulé, AS | 1 |
| Reynaert, H | 1 |
| Fernandes, E | 1 |
| Bourgain, C | 1 |
| Smekens, L | 1 |
| Devis, G | 1 |
| Kader, SA | 1 |
| Mansour, AM | 1 |
| Mohran, Z | 1 |
| el-Taoil, A | 1 |
| Abdalla, KF | 1 |
| Brieva, L | 1 |
| Ara, JR | 1 |
| Bertol, V | 1 |
| Canellas, A | 1 |
| del Agua, C | 1 |
| Mukherjee, S | 1 |
1 review available for omeprazole and Giardia duodenalis Infection
| Article | Year |
|---|---|
Anti-
Topics: Animals; Antiprotozoal Agents; Benzimidazoles; Drug Delivery Systems; Drug Discovery; Drug Therapy, | 2020 |
9 other studies available for omeprazole and Giardia duodenalis Infection
| Article | Year |
|---|---|
Multilevel Approach for the Treatment of Giardiasis by Targeting Arginine Deiminase.
Topics: Animals; Antiprotozoal Agents; Computer Simulation; Cysteine; Drug Evaluation, Preclinical; Drug Rep | 2021 |
Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation.
Topics: Antiprotozoal Agents; Binding Sites; Giardia; Giardiasis; Humans; Molecular Structure; Omeprazole; P | 2017 |
Giardia intestinalis in patients with nonulcer dyspepsia.
Topics: Adolescent; Adult; Antiprotozoal Agents; Drug Therapy, Combination; Duodenum; Dyspepsia; Enzyme-Link | 2013 |
[Chronic use of proton-pump inhibitors associated with giardiasis: A rare cause of hypomagnesemic hypoparathyroidism?].
Topics: Deglutition Disorders; Duodenum; Esomeprazole; Female; Giardiasis; Humans; Hypocalcemia; Hypoparathy | 2008 |
[37-year old patient with fever, diarrhea and lymphadenopathy].
Topics: Adult; AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal | 2010 |
Proton-pump inhibition and gastric giardiasis: a causal or casual association?
Topics: Aged; Amoxicillin; Animals; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mu | 1995 |
A study on the relation between proton pump inhibitor and gastric giardiasis.
Topics: Adult; Animals; Anti-Ulcer Agents; Female; Gastric Mucosa; Gastritis; Giardia lamblia; Giardiasis; H | 1998 |
[Polyneuropathy caused by vitamin B12 deficiency secondary to chronic atrophic gastritis and giardiasis].
Topics: Amoxicillin; Anemia, Pernicious; Anti-Bacterial Agents; Antiprotozoal Agents; Bismuth; Duodenitis; E | 1998 |
Asymptomatic giardiasis--an association with proton pump inhibitors?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Gastroesophageal Reflux; Giardias | 2000 |